Alternatives to retatrutide While retatrutide is still in trials, there are other medications already approved by the FDA for treating both type 2 diabetes and obesity/overweight
Nielsen MJF et al
Blood 139:26422652 Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP (2017) Crizanlizumab for the prevention of pain crises in sickle cell disease
This content is for educational purposes only and is not a substitute for medical advice
They reduce future cardiovascular events, such as heart attack and stroke. Many patients with congestive heart failure who had failed to lose weight multiple times with other methods succeeded with this treatment, according to Tavakol
In clinical trials, the typical person lost about 15% of their total body weight while taking semaglutide, and about 12% more weight than people who didnt take the medication